Advertisement Roche, BGI devise MHC region capture technology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roche, BGI devise MHC region capture technology

Roche NimbleGen and BGI have developed a Major Histocompatibility Complex (MHC) region capture technology.

MHC is a large cluster of genes found on the short arm of chromosome 6 including 150 expressing genes which progresses diseases like AIDs, arteriosclerosis, cancers, diabetes and leukemia.

The new technology is based on NimbleGen’s revolutionary process for the enrichment of the MHC region – SeqCap EZ Choice Library.

MHC region capture technology targets the traditional MHC region (3.37MB) and also approximately 1.6Mb of the regions surrounding MHC, providing a total of 4.97Mb (chr6: 28477797-33448354) and includes 8 known haplotypes.